Header Logo

Connection

JORGE E CORTES to Drugs, Generic

Back to Details
This is a "connection" page, showing publications JORGE E CORTES has written about Drugs, Generic.
JORGE E CORTES
Connection Strength
0.041
Drugs, Generic
  1. Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study. Lancet Haematol. 2019 Aug; 6(8):e398-e408.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.